Track Demant A/S — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Demant A/S DEMANT.CO · Stock Open Demant A/S in new tab

359.00 DKK
P/E
29.72
EPS
11.48
P/B
6.41
ROE
23.30
Beta
0.70
Target Price
312.60 DKK
Loading chart...
Key Metrics
Earnings dateFeb. 9, 2027
P/E29.72
EPS11.48
Book Value53.27
Price to Book6.41
Debt/Equity179.22
% Insiders60.003%
Growth
Revenue Growth0.15%
Earnings Growth0.06%
Estimates
Forward P/E21.18
Forward EPS16.11
Target Mean Price312.60

DCF valuation

Model fair value for Demant A/S (DEMANT.CO)
Result
Sign in to run the valuation for DEMANT.CO.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
20 analysts · consensus Buy · mean target 312.60 DKK (low 220.00, high 399.00) · as of 10 Oct 2026
Low 220.00
Mean 312.60
High 399.00
Price 359.00
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Demant A/S Logo Demant A/S Analysis (DEMANT.CO)

Denmark Health Care Official Website Stock

Is Demant A/S a good investment? Demant A/S (DEMANT.CO) is currently trading at 359.00 DKK. Market analysts have a consensus price target of 312.60 DKK. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 29.72. This valuation is generally in line with the broader market.

Earnings Schedule: Demant A/S is expected to release its next earnings report on Feb. 9, 2027. The market consensus estimate for Forward EPS is 16.11.

Investor FAQ

Does Demant A/S pay a dividend?

No, it does not currently pay a dividend.

What asset class is Demant A/S?

Demant A/S is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 9, 2027. The company currently has a trailing EPS of 11.48.

Company Profile

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

Exchange Ticker
PNK (United States) WILLF
FRA (Germany) WDH1.F
CPH (Denmark) DEMANT.CO
Trades
Dividend History paid per year (DKK)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
May 8, 2000 5:1
May 25, 2016 5:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion